Webinars, Pharmaceutical

Contamination Control Strategy (CCS) in practice

24 Jul 2026

Contamination Control Strategy (CCS) has moved from regulatory checkbox to operational discipline across sterile manufacturing. But what does that shift actually look like inside a supplier’s operations, and why should customers care?

In this video interview, Aptar Pharma’s Nicolas Voisin and Audrey Chardonnet (Injectables division) discuss how CCS reshaped daily practice at Aptar Pharma, and what that means for the customers who rely on their sterile components.

By: Nicolas Voisin (Global Quality Senior Director, Aptar Pharma Injectables) Audrey Chardonnet (Global Business Development Director, Aptar Pharma)
Share
24 Jul 2026
Video interview featuring Nicolas Voisin and Audrey Chardonnet from Aptar Pharma Injectables discussing how Contamination Control Strategy (CCS) has shaped operational practices and the implications for customers relying on sterile components.

Learn more about Aptar Pharma Expertise
in Injectable Drug Delivery